Compare · head to head
Aprogen Biologics vs Astellas Pharma
Astellas Pharma ranks higher overall — 360 rank 100 vs 10.
Astellas Pharma leads on Value (85 vs 44), Quality (75 vs 29), Safety (66 vs 34) and Sentiment (50 vs 41).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | Japan |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | X-Small | X-Large |
| ISIN | KR7003060001 | JP3942400007 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 10 | 100 |
| Value | 44 | 85 |
| Quality | 29 | 75 |
| Growth | NR | 62 |
| Safety | 34 | 66 |
| Sentiment | 41 | 50 |
| Quality details | ||
| Profitability | 16 | 69 |
| Cash Truth | 43 | 81 |
Aprogen Biologics vs Whanin PharmAprogen Biologics vs Daewoong PharmaceuticalAprogen Biologics vs Ilyang PharmaceuticalAprogen Biologics vs Sumitomo Dainippon PharmaAdd a third stock →
Full analyses: Aprogen Biologics · Astellas Pharma
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100